Search Results - "Morrow, SA"

Incidence and prevalence of multiple sclerosis in Europe: a systematic review by Kingwell, Elaine, Marriott, James J, Jetté, Nathalie, Pringsheim, Tamara, Makhani, Naila, Morrow, Sarah A, Fisk, John D, Evans, Charity, Béland, Sarah Gabrielle, Kulaga, Sophie, Dykeman, Jonathan, Wolfson, Christina, Koch, Marcus W, Marrie, Ruth Ann

“…Multiple sclerosis (MS) is the most common cause of neurological disability in young adults worldwide and approximately half of those affected are in Europe…”
Get full text

New insights into the use of high dose corticosteroids and plasmapheresis in persons with MOGAD and NMOSD by Kosior, N, Perrier, RL, Casserly, C, Morrow, SA, Racosta, JM

“…•Responses to HDS in persons with MOGAD and NMOSD optic neuritis and myelitis might differ from each other.•EDSS worsens when persons with MOGAD-myelitis do…”
Get full text

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test by Drake, AS, Weinstock-Guttman, B., Morrow, SA, Hojnacki, D., Munschauer, FE, Benedict, RHB

“…The MS Functional Composite (MSFC) is a continuous scale of neurological disability for patients with multiple sclerosis (MS). Cognition is represented by the…”
Get full text

Effects of acute relapses on neuropsychological status in multiple sclerosis patients by Morrow, S. A., Jurgensen, S., Forrestal, F., Munchauer, Frederick E., Benedict, R. H. B.

“…Little is known about neuropsychological status changes in multiple sclerosis (MS) patients experiencing a relapse. The Symbol Digit Modalities Test (SDMT) and…”
Get full text

Neonatal Hyperoxia Enhances the Inflammatory Response in Adult Mice Infected with Influenza A Virus by O'Reilly, Michael A, Marr, Shauna H, Yee, Min, McGrath-Morrow, Sharon A, Lawrence, B. Paige

“…Lungs of adult mice exposed to hyperoxia as newborns are simplified and exhibit reduced function much like that observed in people who had bronchopulmonary…”
Get full text

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks by Morrow, SA, O'Connor, PW, Polman, CH, Goodman, AD, Kappos, L, Lublin, FD, Rudick, RA, Jurgensen, S, Paes, D, Forrestal, F, Benedict, RHB

“…Background and Objectives: Brief cognitive tests to monitor cognitive impairment in patients with multiple sclerosis (MS) are needed. Methods: Performance on…”
Get full text

Multidisciplinary Management of Ataxia Telangiectasia: Current Perspectives by McGrath-Morrow, Sharon A, Rothblum-Oviatt, Cynthia C, Wright, Jennifer, Schlechter, Haley, Lefton-Greif, Maureen A, Natale, Valerie A, Crawford, Thomas O, Lederman, Howard M

“…Ataxia telangiectasia (A-T) is a rare autosomal recessive disease caused by mutations in the ataxia telangiectasia mutated (ATM) gene. In the absence of a…”
Get full text

Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis by Morrow, SA, Weinstock-Guttman, B, Munschauer, FE, Hojnacki, D, Benedict, RHB

“…Background Studies in multiple sclerosis (MS) report conflicting conclusions regarding fatigue and cognition, which may partly be due to the use of small…”
Get full text

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect by Schoedel, Kerri A, Morrow, Sarah A, Sellers, Edward M

“…Pseudobulbar affect (PBA) is a common manifestation of brain pathology associated with many neurological diseases, including amyotrophic lateral sclerosis,…”
Get full text

Familiarity of family physicians with relapse evaluation and treatment in patients with multiple sclerosis by Morrow, SA, Kremenchutzky, M

“…Background: Multiple sclerosis (MS) is a common disabling neurological disease and 85% of cases are relapsing-remitting at onset, with an overall prevalence in…”
Get full text

Vascular Endothelial Growth Factor Receptor 2 Blockade Disrupts Postnatal Lung Development by McGrath-Morrow, Sharon A, Cho, Cecilia, Cho, Chung, Zhen, Lijie, Hicklin, Daniel J, Tuder, Rubin M

“…Vascular endothelial growth factor (VEGF) is necessary for normal postnatal lung development and may underlie the structural lung damage that follows hyperoxic…”
Get full text

Validation of the English translation of the Swedish symptom frequency intensity and distress (SFID) scale in persons with multiple sclerosis (PwMS) on interferon beta therapy by Casserly, CS, Bowman, D, Gottberg, K, Gardulf, A, Heisel, M, Morrow, SA

Get full text

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis by Morrow, S A, Stoian, C A, Dmitrovic, J, Chan, S C, Metz, L M

“…Oral prednisone (1)might be a convenient, inexpensive alternative to IV methylprednisolone (IVMP) if the bioequivalent dose was known. We compared the total…”
Get full text

MS patients report excellent compliance with oral prednisone for acute relapses by Morrow, Sarah A, McEwan, Lynn, Alikhani, Katayoun, Hyson, Christopher, Kremenchutzky, Marcelo

“…Multiple Sclerosis is characterized by relapses separated by periods of relative quiescence. High dose intravenous corticosteroid pulses for three to five days…”
Get more information

The influence of small for gestational age status on outpatient bronchopulmonary dysplasia outcomes by Johnson, J, Ryan, T, Aherrera, A D, McGrath-Morrow, S A, Collaco, J M

“…Objective: To describe the characteristics of small for gestational age (SGA) and non-SGA infants with bronchopulmonary dysplasia (BPD) and to ascertain…”
Get full text

The presentation and long-term prognosis of a first demyelinating event, optic neuritis, evaluated by neuro-ophthalmologists by Morrow, SA, Kremenchutzky, M, Nicolle, D, Proulx, A

“…Background: According to the Optic Neuritis Treatment Trial (Beck at al 2003) the 10-year risk of conversion to multiple sclerosis (MS) after acute…”
Get full text

Apoptosis in Neonatal Murine Lung Exposed to Hyperoxia by McGrath-Morrow, Sharon A, Stahl, Jennifer

“…Exposure to high concentrations of oxygen in the neonatal period may impair lung growth and is a major contributing factor to the development of…”
Get full text

The conceptualization and development of a patient-reported neurogenic bladder symptom score by Welk, Blayne, Morrow, Sarah A, Madarasz, Wendy, Potter, Patrick, Sequeira, Keith

“…There is no single patient-reported instrument that was developed specifically to assess symptoms and bladder-related consequences for neurogenic bladder…”
Get full text

High dose oral steroids commonly used to treat relapses in Canadian MS clinics by Morrow, S A, Metz, L M, Kremenchutzky, M

“…Glucocorticoid treatment improves the speed of functional recovery of acute multiple sclerosis (MS) relapses but has not been shown to provide any long-term…”
Get more information

The effect of glutamine on A549 cells exposed to moderate hyperoxia by Ogunlesi, Folasade, Cho, Cecilia, McGrath-Morrow, Sharon A.

“…The use of high oxygen concentrations is frequently necessary in the treatment of acute respiratory distress syndrome (ARDS) and bronchopulmonary dysplasia…”
Get full text